Literature DB >> 24326884

Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography.

Satoshi Okayama1, Tsunenari Soeda, Rika Kawakami, Yasuhiro Takami, Satoshi Somekawa, Tomoya Ueda, Yu Sugawara, Takaki Matsumoto, Ji Hee Sung, Taku Nishida, Shiro Uemura, Yoshihiko Saito.   

Abstract

Coronary artery disease and cardiac morphology and function were evaluated in 51 patients with hypertrophic cardiomyopathy (HCM), without typical chest pain, using cardiac computed tomography (CT). This study investigated the prevalence of coronary artery disease, the indicators of obstructive coronary stenosis, and the magnitude of left ventricular (LV) hypertrophy. The patients' mean coronary artery calcium score was 198.8 ± 312.0 and was positively correlated with the number of coronary risk factors (r = 0.32; P < 0.05). Of the 51 patients with HCM, 42 (82.4 %) had some degree of stenosis and 8 (15.7 %) had obstructive stenosis. Noncalcified and mixed plaques were detected in 14 (27.5 %) and 11 (21.6 %) patients, respectively. Multivariate logistic regression revealed that diabetes was an independent indicator of the presence of obstructive stenosis in HCM patients. Multivariate linear regression revealed that low estimated glomerular filtration rates and high triglyceride concentrations were independent indicators of higher LV mass indexes. In conclusion, cardiac CT revealed that coronary artery disease was common among patients with HCM. The presence of obstructive coronary stenosis and the magnitude of LV hypertrophy were related to the presence of diabetes, triglyceride levels, and estimated glomerular filtration rate.

Entities:  

Mesh:

Year:  2013        PMID: 24326884     DOI: 10.1007/s00380-013-0452-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  36 in total

1.  Assessing myocardial bridging and left ventricular configuration by 64-slice computed tomography in patients with apical hypertrophic cardiomyopathy presenting with chest pain.

Authors:  Chao-Chin Chen; Ming-Tsung Chen; Meng-Huan Lei; Yu-Cheng Hsu; Sheng-Liang Chung; Yen-Jen Sung
Journal:  J Comput Assist Tomogr       Date:  2010-01       Impact factor: 1.826

2.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.

Authors:  I Olivotto; F Cecchi; S A Casey; A Dolara; J H Traverse; B J Maron
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

4.  Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.

Authors:  Tsunenari Soeda; Shiro Uemura; Satoshi Okayama; Rika Kawakami; Yu Sugawara; Hitoshi Nakagawa; Takaki Matsumoto; Ji-Hee Sung; Taku Nishida; Ayako Senoo; Satoshi Somekawa; Yukiji Takeda; Kenichi Ishigami; Hiroyuki Kawata; Manabu Horii; Yoshihiko Saito
Journal:  Circ J       Date:  2011-08-06       Impact factor: 2.993

5.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

6.  Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging.

Authors:  J Sandstede; C Lipke; M Beer; S Hofmann; T Pabst; W Kenn; S Neubauer; D Hahn
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

7.  Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women.

Authors:  Giuseppe Schillaci; Matteo Pirro; Giacomo Pucci; Massimo R Mannarino; Fabio Gemelli; Donatella Siepi; Gaetano Vaudo; Elmo Mannarino
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

8.  Evaluation of epicardial and intra-myocardial fat in a patient with mitochondrial cardiomyopathy.

Authors:  Satoshi Okayama; Shiro Uemura; Yoshihiko Saito
Journal:  Int J Cardiol       Date:  2013-04-11       Impact factor: 4.164

9.  Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy.

Authors:  Paola Melacini; Cristina Basso; Annalisa Angelini; Chiara Calore; Fabiana Bobbo; Barbara Tokajuk; Nicoletta Bellini; Gessica Smaniotto; Mauro Zucchetto; Sabino Iliceto; Gaetano Thiene; Barry J Maron
Journal:  Eur Heart J       Date:  2010-05-31       Impact factor: 29.983

10.  Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.

Authors:  Etsuko Fujita; Toshio Nakanishi; Tsutomu Nishizawa; Nobuhisa Hagiwara; Rumiko Matsuoka
Journal:  Heart Vessels       Date:  2013-03-14       Impact factor: 2.037

View more
  8 in total

1.  2D speckle-tracking TTE-based quantitative classification of left ventricular myocardium in patients with hypertrophic cardiomyopathy by the presence or the absence of fibrosis and/or hypertrophy.

Authors:  Nobusada Funabashi; Hiroyuki Takaoka; Koya Ozawa; Masae Uehara; Issei Komuro; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-03-22       Impact factor: 2.037

2.  Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy.

Authors:  Lei Zhao; Xiaohai Ma; Hailong Ge; Chen Zhang; Zhanhong Wang; Kunihiko Teraoka; Zhanming Fan
Journal:  Eur Radiol       Date:  2014-10-31       Impact factor: 5.315

3.  Characteristic systolic waveform of left ventricular longitudinal strain rate in patients with hypertrophic cardiomyopathy.

Authors:  Kazunori Okada; Sanae Kaga; Taisei Mikami; Nobuo Masauzi; Ayumu Abe; Masahiro Nakabachi; Shinobu Yokoyama; Hisao Nishino; Ayako Ichikawa; Mutsumi Nishida; Daisuke Murai; Taichi Hayashi; Chikara Shimizu; Hiroyuki Iwano; Satoshi Yamada; Hiroyuki Tsutsui
Journal:  Heart Vessels       Date:  2016-10-18       Impact factor: 2.037

4.  Effects of flecainide on left ventricular pressure gradient and symptoms in obstructive hypertrophic cardiomyopathy: a comparison of flecainide and disopyramide.

Authors:  Shintaro Haruki; Yuichiro Minami; Atsushi Suzuki; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2014-06-12       Impact factor: 2.037

5.  Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population.

Authors:  Ze-Min Yang; Long-Hui Chen; Min Hong; Ying-Yu Chen; Xiao-Rong Yang; Si-Meng Tang; Qian-Fa Yuan; Wei-Wen Chen
Journal:  Mol Med Rep       Date:  2017-02-22       Impact factor: 2.952

6.  Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Hang Liao; Huay Cheem Tan; Ziqiong Wang; Xiaoping Chen; Yong He; Sen He
Journal:  BMC Cardiovasc Disord       Date:  2021-07-03       Impact factor: 2.298

7.  Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.

Authors:  Jing Liu; Ling Jing; Xilin Tu
Journal:  BMC Cardiovasc Disord       Date:  2016-03-05       Impact factor: 2.298

8.  Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy.

Authors:  Joshua R Smith; Jose R Medina-Inojosa; Veronica Layrisse; Steve R Ommen; Thomas P Olson
Journal:  J Clin Med       Date:  2018-11-18       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.